NEW YORK, Aug. 12, 2025 /PRNewswire/ -- HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined the prestigious Mayo Clinic Platform Accelerate program. This partnership grants HopeAI access to Mayo Clinic's world-class...
Hence then, the article about hopeai joins mayo clinic platform to transform the future of drug development with ai was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( HopeAI Joins Mayo Clinic Platform to Transform the Future of Drug Development with AI )
Also on site :
- Northern Ethiopia’s shifting alliances explained
- ‘The Blue Trail’ Director Gabriel Mascaro and Top Brazilian Producer Paula Cosenza Launch Trema, Set First Slate (EXCLUSIVE)
- Trump says he only talks to his children to say ‘I love you’ not about his billion-dollar crypto businesses